Corpus Intelligence IC Memo — ANIMAS SURGICAL HOSPITAL 2026-04-26 15:54 UTC
IC Memo — ANIMAS SURGICAL HOSPITAL
Investment Committee Memorandum | CO | 12 beds | Grade C | EBITDA uplift $3.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ANIMAS SURGICAL HOSPITAL

CCN 060117 | LA PLATA, CO | 12 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ANIMAS SURGICAL HOSPITAL is a 12-bed suburban community hospital in LA PLATA, CO with $47.4M in net patient revenue and a 13.7% operating margin. The hospital serves a payer mix of 20.6% Medicare, 1.5% Medicaid, and 77.9% commercial.

Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.7% to 21.0% (+736bps).

Net Revenue HCRIS$47.4M
Current EBITDA COMPUTED$6.5M
Operating Margin COMPUTED13.7%
Occupancy HCRIS26.5%
Revenue / Bed COMPUTED$4.0M
Net-to-Gross HCRIS27.9%
Distress Probability ML48.0%

2. Market Context & Competitive Position

108
CO Hospitals
-3.6%
State Median Margin
21
Comparable Hospitals

CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 13.7% places it above the state median. Among 21 size-comparable peers (6-24 beds), the median margin is -7.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-24), prioritizing same-state peers. 21 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ANIMAS SURGICAL HOSPITAL (Target)CO12$47.4M13.7%
NATIONAL JEWISH HEALTHCO13$150.4M-50.0%
SOUTHWEST MEMORIAL HOSPITALCO23$74.6M-4.5%
GUNNISON VALLEY HOSPITALCO20$63.3M2.8%
UCHEALTH BROOMFIELD HOSPITALCO20$60.3M-8.5%
KREMMLING MEMORIAL HOSPITAL DICO22$50.0M0.6%
PIONEERS MEDICAL CENTERCO16$43.9M-5.9%
UCHEALTH GRANDVIEW HOSPITALCO22$43.5M-13.2%
ARKANSAS VALLEY REGL MED CTRCO20$37.1M-5.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$996K+210bp18mo
Cost to Collect4.5%2.5%$949K+200bp12mo
Denial Rate Reduction12.0%6.5%$939K+198bp12mo
A/R Days Reduction5200.0%3800.0%$577K+122bp9mo
Clean Claim Rate88.0%96.0%$30K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$996K
Cost to Collect
$949K
Denial Rate Reduction
$939K
A/R Days Reduction
$577K
Clean Claim Rate
$30K
Total EBITDA Uplift$3.5M
Current EBITDA$6.5M
+ RCM Uplift+$3.5M
Pro Forma EBITDA$10.0M
Current Margin13.7%
Pro Forma Margin21.0%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$10.0M$77.7M7.79x50.7%
Base (11x exit)10.0x11.0x$10.0M$88.7M8.89x54.8%
Bull Case9.0x11.0x$9.0M$103.5M11.52x63.0%
Bull (12x exit)9.0x12.0x$9.0M$115.6M12.86x66.7%
Bear Case11.0x10.0x$11.0M$57.0M5.19x39.0%
Bear (11x exit)11.0x11.0x$11.0M$66.3M6.04x43.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 26.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 21 hospitals with 6-24 beds
  • Same-state prioritization (n=24)
  • Comp margins: P25=-15.7% / P50=-7.9% / P75=-2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.